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Abstract
Background: Breast cancer is the leading cause of cancer death in women in Australia. Early
detection provides the best chance of reducing mortality and morbidity from the disease.
Mammographic screening is a population health strategy for the early detection of breast cancer in
Australia. Recruitment strategies such as regular advertising and biannual screening invitations are
exclusively targeted at women aged 50 – 69 years. Even though they can participate, women 70
years or over are not invited or actively encouraged to undertake screening. Research has found
that a routine letter of invitation increases the number of women participating in breast cancer
screening.
Methods: Cancer data analysis and a literature and policy review was conducted to assess age
specific breast cancer mortality rates and the legitimacy of rationale used to limit invitations for
breast cancer screening to women younger than 70 years.
Results: The proportion of women over 69 years participating in the BreastScreen program is
significantly less than rate of screening in the target age range (50–69 years). Evidence and data
indicate that common justifications for limiting screening reminders to the target age range
including life expectancy, comorbidities, effectiveness, treatment and cost are, for many women,
unreasonable.
Conclusion: There is now sufficient data to support a change in the targeted upper age range for
breast cancer screening to improve the existing suboptimal surveillance in women aged over 69
years.
Background
Breast cancer is the most common invasive cancer diag-
nosed in females in Australia and is the leading cause of
cancer death in this group [1]. Age is the most important
single risk factor for disease development and death rates
increase consistently with advancing age [2]. In 2005, the
death rate per 100,000 for women aged 40–44 years was
17.0 increasing to 66 per 100,000 in women aged 65–69
years and escalating to 182.0 deaths per 100,000 in
women aged 85 years or over [2]. The annual number of
years of potential life lost due to female breast cancer in
Australia is over 32,000 [3]. Long life expectancy is
regarded as an indicator of a successful society and an
effective health care system [4].
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Mammography has been demonstrated to reduce morbid-
ity and mortality from breast cancer [5] through early dis-
ease detection, which, when managed effectively, leads to
improved survival and less aggressive treatment [3]. At
this time, mammography is the only accepted screening
modality for breast cancer in average risk populations [6].
BreastScreen Australia is the national breast cancer screen-
ing program offering free mammography screening to
asymptomatic women since 1991. A clear upper age limit
has not been set for breast cancer screening in Australia;
however, recruitment strategies are specifically targeted at
women aged 50 – 69 years who are reminded to have a
mammogram every two years via written invitations [7].
Women aged 40–49 and 70 years or over are not invited
for screening, although they are able to participate [7].
Research has found that a routine letter of invitation
increases the number of women participating in breast
cancer screening [8,9].
Methods
An examination of recent national cancer data was under-
taken to assess age specific breast cancer mortality rates
and a literature and policy review was conducted to assess
the legitimacy of rationale used to limit invitations for
breast cancer screening to women younger than 70 years
of age.
Results
There has been a slow decline in the number of women
older than 69 years participating in the national Breast-
Screen program over the past decade, with only 11% of
women in this age group participating in 2004–5 [3]. This
compares very poorly with participation rates of the tar-
geted age range, which have steadily increased over the
past decade and currently sit at almost 74% [3]. Figure 1
compares death rates from female breast cancer with
BreastScreen participation rates, demonstrating that
A comparison of death rates from female breast cancer in 2005 with BreastScreen participation rates in 2004–5 Figure 1
A comparison of death rates from female breast cancer in 2005 with BreastScreen participation rates in 2004–
5. Data source: Ref [3] Australian Institute of Health and Welfare 2008. BreastScreen Australia monitoring report 2004–2005. 
Cancer series no. 42. Cat. no. CAN 37.
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underscreening has a strong negative effect on breast can-
cer survival.
One reason given for targeting women 50–69 years for
screening is that early detection in this age group offers
women "a better chance of successful treatment and
recovery" presumably, because of a higher likelihood of
comorbid conditions, reduced treatment tolerance and
shorter life expectancy in women above 69 years [10].
Another reason given is that most of the research showing
mammographic screening effectiveness was conducted
with women aged 50–69 years [10]. The national Breast-
Screen  policy states that the age for screening will be
"monitored and reviewed as new data become available"
[5]. A program review is currently underway to assess the
appropriateness of the existing BreastScreen Australia tar-
geted age range [11].
Effectiveness
In the past, elderly women have been significantly under-
represented in the evidence base used to determine the
effectiveness of mammography. Researchers used age lim-
its in recruitment as cut off points to minimise potential
problems caused by comorbid health conditions and the
risk of loss to follow up from unexpected early death [12].
This has contributed to the lack of clear policy guidelines
and resultant under-surveillance of breast cancer in eld-
erly women.
A recent study with over 860,000 participants aged
between 70–75 years has shown that breast cancer screen-
ing using mammography reduces deaths from the disease
in women in this age group. This study also found that
screening did not cause significant harm by exposing the
older women to over-diagnosis and over-treatment [13].
Numerous other investigations support targeted mammo-
graphic breast cancer screening in older age groups, [14-
20] including a 2007 review [21] which found that there
is now sufficient data to support regular screening above
age 75 years based on individual assessment.
Life expectancy
The size of the older population in Australia is growing,
with females representing an increasing proportion of the
population. At age 70, the average life expectancy of a
woman living in Australia is over 15 years [22]. Many of
these women, if in sound health, will live considerably
longer than the average life expectancy and will remain at
risk for breast cancer development and recurrence.
Approximately 25% of women 75 years of age will live
more than 17 years and 50% will live at least another 12
years [23]. There are approximately 56,000 female octoge-
narians currently living in Australia. This number is
increasing and is predicted to reach approx 69,000 by
2020 and 107,000 by 2027 [23].
Comorbidity
The existence of comorbid conditions has been used as
rationale to exclude women over 69 years in breast cancer
screening invitations. The findings of the most recent Aus-
tralian Bureau of Statistics National Health Survey indicate
that almost all people aged 65 years or older have at least
one persistent health problem and around 80% reporting
three or more [24]. The most frequently reported long
term conditions are problems with eyesight, hayfever/
allergic rhinitis, arthritis and back and disc disorders
[24,25]. Considering the most commonly reported
chronic conditions and the expected large heterogeneity
in the health status of this older population, many
women in older age groups will not have comorbidity
severe enough to negate the benefits in survival and qual-
ity of life gained from breast cancer screening.
Research [26,27] and projections [28] based on trends of
improvements in health generally, including changing
levels of fitness in all age groups, indicate that the total
burden of chronic disease will decline significantly in the
next three to four decades. Moreover, gerontological
research has now identified factors that can predict which
women are likely to remain in good health and which
may not. For example, progressive dependence on others
for support in daily living activities can predict reduced
survival over the intermediate term [29-31].
Treatment
The ability of elderly women to endure cancer treatment
has been raised in the breast screening debate. Yet, less
invasive surgical procedures and better targeting of breast
cancer treatments strengthen support for the involvement
of older women in breast cancer screening programs
[32,33]. A large body of evidence demonstrates that fit
older women who have breast cancer can safely undergo
the same treatments and show equal tolerance as their
younger counterparts with comparable results. [34-40]
Cost
Resource limitation has also been given as a possible
underlying reason for not encouraging routine screening
older women. However, cost-effectiveness analyses sug-
gest that breast cancer screening after the age of 65 years
reduces mortality at reasonable costs in women who are
without significant comorbidities and that it is likely to be
worthwhile until a woman has an estimated life expect-
ancy of between five and 10 years [41,42]. Interventions
to purposely foster participation in screening mammogra-
phy among women 65 years and older are being
researched internationally [43].
Community views
In 1997, Glasziou highlighted the importance of involv-
ing target groups in screening decisions in order toAustralia and New Zealand Health Policy 2008, 5:23 http://www.anzhealthpolicy.com/content/5/1/23
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develop "rational and acceptable policy" around breast
cancer screening [44]. Breast Cancer Network Australia, a
22,000 member organisation, is the national organisation
representing Australians affected by breast cancer. This
group advocates for 'the availability of free mammogra-
phy to be promoted to all women over 40, not just the tar-
get age of 50–69' [45]. Similarly, Cancer Voices NSW, the
independent, peak advocacy organisation for all people
affected by cancer in New South Wales, with over 4,000
members, advocates for an increase in breast cancer
screening promotion by government. Moreover, this
organisation seeks for 'the adoption by government of the
principles of cancer consumer participation wherever
decisions affecting them are made' [46]. The Breast Cancer
Action Groups in NSW and Victoria have long advocated
for screening reminders to be made available for women
aged 70 and over [47].
The Australian community as a whole benefits from eld-
erly members who are in good health and are given the
opportunity to reach an average life expectancy at a mini-
mum. Their contribution to childcare and other unpaid
caring duties; financial, practical and emotional assistance
to family members and friends, and voluntary work has
been reported to add up to around 7% of the gross domes-
tic product [48].
Overseas not-for-profit community support organisations
also advocate for organised breast cancer screening for the
elderly. The American Cancer Society advises women to
continue breast cancer screening as long as they are in
good health and are suitable candidates for cancer treat-
ment [49] and the American Geriatrics Society [50,51] rec-
ommends that screening should be individualised, rather
than age-driven alone, recommending no upper age limit
for screening, as long as estimated life expectancy is 4
years or more.
Discussion
Detection of early stage breast cancers offers the potential
for longer survival and enhanced quality of life for many
women irrespective of age. There is a pressing need to
assemble all relevant evidence, including community
needs, with regard to breast cancer screening in the elderly
and translate it into a cohesive policy.
We acknowledge that at policy level, making decisions
around screening age is a complex process, but age alone
should not be a criterion for discontinuing invitations to
attend regular breast screening. Screening may not be suit-
able for all, as some women may have other health prob-
lems that would reduce the long-term benefit of screening
or may choose not to screen for other reasons. For others,
screening may provide some additional life years, that
might otherwise be lost. Regardless of which position
women take, the opportunity to weigh up the potential
benefits and risks of mammography needs to be available
to all if they so choose.
Decision-making aids, in conjunction with opportunities
to discuss these decisions with their healthcare providers
can assist women define their individual position around
whether they wish to attend repeat screening. This infor-
mation can be fed back to BreastScreen through an opt-off
process, closing the loop on consumer involvement and
improving public communication. Continuing the recall
system, while providing realistic opportunities for women
to examine benefit-harm tradeoffs would ensure that
breast cancer screening remains equitable in all age
groups and that beneficiaries can avail themselves of this
service, fully informed of the consequences of their deci-
sions.
Conclusion
With the growing number of older women in Australia,
breast cancer will become an increasingly significant
health concern, yet there is suboptimal surveillance of
breast cancer in those aged over 69 years. Prompts to con-
tinue breast cancer screening are currently provided on the
basis of chronological age alone. Continuing reminders
after aged sixty nine and adopting a patient centred
approach (which takes the form of an informed, shared,
decision-making process between a woman and her med-
ical practitioner) for individual decisions about screening
is proposed.
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